Your browser doesn't support javascript.
loading
Ultrasound versus palpation-guided corticosteroid injection for de Quervain disease: A randomized controlled trial.
Kuo, Ying-Chen; Hsieh, Lin-Fen; Liu, Ya-Fang; Chang, Chia-Sung.
Afiliación
  • Kuo YC; Department of Physical Medicine & Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
  • Hsieh LF; School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
  • Liu YF; Department of Physical Medicine & Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
  • Chang CS; School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
PM R ; 2024 Apr 22.
Article en En | MEDLINE | ID: mdl-38647254
ABSTRACT

INTRODUCTION:

Corticosteroid injection effectively treats de Quervain disease, and due to the high prevalence of the intracompartmental septum in the first extensor compartment, ultrasound guidance improves injection accuracy.

OBJECTIVE:

To compare the effectiveness, adverse events, and the recurrence rate between ultrasound-guided and palpation-guided injection in patients with de Quervain disease.

DESIGN:

Prospective, single-blind, randomized controlled trial.

SETTING:

Rehabilitation department of a private teaching hospital.

PARTICIPANTS:

We enrolled 49 patients, ≥20 years of age, clinically diagnosed with de Quervain disease based on their medical history and physical examination.

INTERVENTIONS:

Patients were randomized into two groups ultrasound-guided and palpation-guided injection. Both groups received a mixture of 10 mg triamcinolone acetonide (10 mg/1 mL) and 0.3 mL 1% lidocaine. MAIN OUTCOME

MEASURES:

The primary outcome measure was the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) score at 1 week. The secondary outcome measures were visual analog scale for pain (pain VAS) score, patient satisfaction, and adverse events or complications from the interventions at 1 week, 3 months, and 6 months.

RESULTS:

Both groups showed improvement over time in QuickDASH scores and pain VAS (p < .001); however, no statistically significant differences were noted between the groups for either QuickDASH scores (p = .22) or pain VAS (p = .30). In addition, no statistically significant differences were found between the groups in terms of patient satisfaction (p = .76) and adverse events (p = .47, .33, .58) at the 1-week, 3-month, and 6-month follow-ups.

CONCLUSIONS:

Both ultrasound-guided and palpation-guided injections effectively treated de Quervain disease. During a 6-month follow-up, there were no statistically significant differences between the groups in pain relief, upper limb function, or patient satisfaction. However, the palpation-guided group showed a tendency for more recurrence and skin side effects.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PM R Asunto de la revista: MEDICINA FISICA / REABILITACAO / TRAUMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: PM R Asunto de la revista: MEDICINA FISICA / REABILITACAO / TRAUMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Taiwán